Resistensudvikling drives foruden af den anvendte absolutte mængde quinoloner også af farmakokinetiske og farmakodynamiske (PK/ PD) faktorer.
Resistance development is beside absolute quantitative use of quinolone agents also driven by pharmacokinetic and pharmacodynamic (PK/ PD) factors.